Tag - pharmaceuticals

 
Menu
Search
 
November 22, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICALS

Japan Times
WORLD / Science & Health
Oct 18, 2022
High hopes for nasal COVID-19 vaccines despite 'disappointing' trial
By entering the body the same way as the virus, nasal vaccines aim to build immunity in the mucous membrane that line the nose and mouth.
Japan Times
COMMENTARY / World
Oct 4, 2022
New Alzheimer's drug from Biogen and Eisai is just the beginning
A successful late-stage trial of lecanemab gives researchers promising new avenues for tackling this hard-to-beat disease.
Japan Times
WORLD / Science & Health / ANALYSIS
Sep 30, 2022
Eisai drug's trial success raises hope for Alzheimer's prevention
Scientists have already begun to debate whether the benefit of the drug is robust enough, but to many researchers, the findings suggest that preventing decline altogether is possible.
Japan Times
ASIA PACIFIC / Science & Health
Sep 30, 2022
A Chinese mRNA COVID vaccine gets its first approval — in Indonesia
Indonesia's food and drugs agency approved the use of Walvax Biotechnology's mRNA vaccine, which has been in development for more than two years.
Japan Times
JAPAN / Science & Health
Sep 28, 2022
Shionogi says COVID-19 pill trial shows reduction in symptoms
The drug met the trial's goal of reducing five key symptoms of the omicron variant within 72 hours of onset, the company said.
Japan Times
JAPAN / Science & Health
Sep 28, 2022
Alzheimer’s progression slowed by drug in major trial
The drug slowed cognitive decline in people with early Alzheimer's by 27% over 18 months when compared with a placebo using a common rating scale.
Japan Times
JAPAN
Sep 12, 2022
Japan health ministry backs Pfizer and Moderna omicron boosters
Pfizer's omicron booster can be administered to people age 12 and over, while Moderna's is limited to those 18 and above, the panel advised.
Japan Times
WORLD / Science & Health
Aug 17, 2022
Why a century-old vaccine offers new hope against pathogens
The B.C.G. tuberculosis vaccine may protect against COVID-19 and other infections by broadly bolstering the immune system.
Japan Times
WORLD / Science & Health
Jul 26, 2022
Siga and peers rise on optimism over therapies to treat monkeypox
It has been a bumpy few months for shares of firms tied to the outbreak, as investors have piled in only to rush out on uncertainty about what medicine could be needed.
Japan Times
BUSINESS / Companies
Jul 6, 2022
Eisai says Alzheimer’s drug will get priority review in U.S.
Under the accelerated approval pathway, drugs can be approved based on their ability to remove amyloid, a hallmark of the disease, from the brain.
Japan Times
WORLD / Science & Health
Apr 27, 2022
With supply more abundant, U.S. pharmacies struggle to use up COVID pills
The rollout of the COVID-19 treatment Paxlovid has been far more complicated and less efficient than expected, leaving hundreds of thousands of courses unused.
Japan Times
BUSINESS / Companies
Apr 22, 2022
U.S. in talks with Japan's Shionogi to buy new COVID-19 pill
Shionogi's treatment is in late-stage clinical trials and hasn't yet been authorized, but in earlier studies, it reduced viral loads in patients within the first few days of use.
Japan Times
WORLD / Science & Health
Apr 12, 2022
India hopes ‘Pharma City’ will break China’s grip on industry
It's a vast project that shows how governments are growing increasingly concerned about China's stranglehold over drug supplies — as well as the challenges they face in loosening it.
Japan Times
WORLD
Mar 29, 2022
World moves from shortages to possible glut of COVID-19 vaccines
Even as boosters are likely to keep demand alive for COVID-19 inoculations worldwide, the desperate shortages that existed for much of last year have waned.
Japan Times
BUSINESS / Companies
Mar 25, 2022
Shionogi signs supply deal with Japanese government for COVID-19 pill
The government is considering buying a million doses of the drug, pending regulatory approval.
Two of America’s biggest debt holders are dumping Treasurys
The U.S. Treasury building in Washington. Investors in Japan and China sold a pile of U.S. debt in the last quarter, just before the U.S. presidential election.
Ishiba aggravates his own political failures with diplomatic faux pas
Prime Minster Shigeru Ishiba is greeted at the APEC summit in Lima by Canadian Prime Minister Justin Trudeau on Friday. The Japanese leader was criticized for remaining seated while meeting several world leaders at the event.
Japan's 3.31 million visitors in October set monthly record
Kiyomizu Temple in Kyoto in December 2023. Famous autumn leaf colors contributed to increased tourism demand last month from many markets across Asia, Europe and North America, the Japan National Tourism Organization has said.
Japan ranks last in romance satisfaction for second straight year
In a survey of 31 countries, Japan ranked last in terms of those who felt loved, with just 51% of respondents saying so.
Ruling coalition and DPP strike last-minute deal over economic policy
DPP policy chief Makoto Mahaguchi speaks at the party's policy gathering in Tokyo on Wednesday.
Japan, U.K. and Italy discuss inviting more countries to joint fighter project
A new concept model of a next-generation fighter jet to be jointly developed by Japan, Britain and Italy is on display in Farnborough, Hampshire, in July.
Haruki Murakami's 'The City and Its Uncertain Walls' gives deep deja vu
For “The City and Its Uncertain Walls,” translated into English by Philip Gabriel, Haruki Murakami confronts the ghosts who won't leave him alone.
Japanese expats in Asia find community through rugby
The Taiwan Fivewoods celebrate their victory at the 2023 Asian Japanese Rugby Cup in December of last year.
In Fukushima, a weekend of prose, poetry and translation
Aomori-based writer JJ Carter presented on tabletop gaming as creative inspiration for building characters and narratives.
For Dr. Nakamats, aging is just experience in action
Though he didn't win the recent gubernatorial election in Tokyo, the 96-year-old Dr. Nakamats' run was seen as inspirational in Japan's aging society.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?
By Kathryn Wortley

SUSTAINABLE JAPAN

The celebrated artist ‘updating’ the kimono
The celebrated artist ‘updating’ the kimono

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER